331 related articles for article (PubMed ID: 28007424)
21. CRISPR/Cas9 genome editing in human pluripotent stem cells: Harnessing human genetics in a dish.
González F
Dev Dyn; 2016 Jul; 245(7):788-806. PubMed ID: 27145095
[TBL] [Abstract][Full Text] [Related]
22. Lessons from the heart: mirroring electrophysiological characteristics during cardiac development to in vitro differentiation of stem cell derived cardiomyocytes.
van den Heuvel NH; van Veen TA; Lim B; Jonsson MK
J Mol Cell Cardiol; 2014 Feb; 67():12-25. PubMed ID: 24370890
[TBL] [Abstract][Full Text] [Related]
23. Microcarrier-based platforms for in vitro expansion and differentiation of human pluripotent stem cells in bioreactor culture systems.
Badenes SM; Fernandes TG; Rodrigues CAV; Diogo MM; Cabral JMS
J Biotechnol; 2016 Sep; 234():71-82. PubMed ID: 27480342
[TBL] [Abstract][Full Text] [Related]
24. Human pluripotent stem cell based islet models for diabetes research.
Balboa D; Otonkoski T
Best Pract Res Clin Endocrinol Metab; 2015 Dec; 29(6):899-909. PubMed ID: 26696518
[TBL] [Abstract][Full Text] [Related]
25. Maturing human pluripotent stem cell-derived cardiomyocytes in human engineered cardiac tissues.
Feric NT; Radisic M
Adv Drug Deliv Rev; 2016 Jan; 96():110-34. PubMed ID: 25956564
[TBL] [Abstract][Full Text] [Related]
26. Biowire platform for maturation of human pluripotent stem cell-derived cardiomyocytes.
Sun X; Nunes SS
Methods; 2016 May; 101():21-6. PubMed ID: 26546730
[TBL] [Abstract][Full Text] [Related]
27. Modulation of human mesenchymal and pluripotent stem cell behavior using biophysical and biochemical cues: A review.
Ding S; Kingshott P; Thissen H; Pera M; Wang PY
Biotechnol Bioeng; 2017 Feb; 114(2):260-280. PubMed ID: 27531179
[TBL] [Abstract][Full Text] [Related]
28. Comparative transcriptomics of hepatic differentiation of human pluripotent stem cells and adult human liver tissue.
Ghosheh N; Küppers-Munther B; Asplund A; Edsbagge J; Ulfenborg B; Andersson TB; Björquist P; Andersson CX; Carén H; Simonsson S; Sartipy P; Synnergren J
Physiol Genomics; 2017 Aug; 49(8):430-446. PubMed ID: 28698227
[TBL] [Abstract][Full Text] [Related]
29. Perspective from the heart: the potential of human pluripotent stem cell-derived cardiomyocytes.
Xu XQ; Sun W
J Cell Biochem; 2013 Jan; 114(1):39-46. PubMed ID: 22903726
[TBL] [Abstract][Full Text] [Related]
30. Differentiation and enrichment of cardiomyocytes from human pluripotent stem cells.
Xu C
J Mol Cell Cardiol; 2012 Jun; 52(6):1203-12. PubMed ID: 22484618
[TBL] [Abstract][Full Text] [Related]
31. Engineering cell aggregates through incorporated polymeric microparticles.
Ahrens CC; Dong Z; Li W
Acta Biomater; 2017 Oct; 62():64-81. PubMed ID: 28782721
[TBL] [Abstract][Full Text] [Related]
32. Large-scale production of human pluripotent stem cell derived cardiomyocytes.
Kempf H; Andree B; Zweigerdt R
Adv Drug Deliv Rev; 2016 Jan; 96():18-30. PubMed ID: 26658242
[TBL] [Abstract][Full Text] [Related]
33. Substrate and mechanotransduction influence SERCA2a localization in human pluripotent stem cell-derived cardiomyocytes affecting functional performance.
Martewicz S; Serena E; Zatti S; Keller G; Elvassore N
Stem Cell Res; 2017 Dec; 25():107-114. PubMed ID: 29125993
[TBL] [Abstract][Full Text] [Related]
34. Pluripotent stem cell models of cardiac disease and their implication for drug discovery and development.
Davis RP; van den Berg CW; Casini S; Braam SR; Mummery CL
Trends Mol Med; 2011 Sep; 17(9):475-84. PubMed ID: 21703926
[TBL] [Abstract][Full Text] [Related]
35. Spatial Stem Cell Fate Engineering via Facile Morphogen Localization.
Jin G; Floy ME; Simmons AD; Arthur MM; Palecek SP
Adv Healthc Mater; 2021 Nov; 10(21):e2100995. PubMed ID: 34459150
[TBL] [Abstract][Full Text] [Related]
36. Applications of genetically engineered human pluripotent stem cell reporters in cardiac stem cell biology.
Zhang JZ; Guo H; Wu JC
Curr Opin Biotechnol; 2018 Aug; 52():66-73. PubMed ID: 29579626
[TBL] [Abstract][Full Text] [Related]
37. Pluripotent stem cell models of human heart disease.
Moretti A; Laugwitz KL; Dorn T; Sinnecker D; Mummery C
Cold Spring Harb Perspect Med; 2013 Nov; 3(11):. PubMed ID: 24186488
[TBL] [Abstract][Full Text] [Related]
38. Genome editing in pluripotent stem cells: research and therapeutic applications.
Deleidi M; Yu C
Biochem Biophys Res Commun; 2016 May; 473(3):665-74. PubMed ID: 26930470
[TBL] [Abstract][Full Text] [Related]
39. Biomarkers of Human Pluripotent Stem Cell-Derived Cardiac Lineages.
Skelton RJP; Kamp TJ; Elliott DA; Ardehali R
Trends Mol Med; 2017 Jul; 23(7):651-668. PubMed ID: 28576602
[TBL] [Abstract][Full Text] [Related]
40. Current Strategies and Challenges for Purification of Cardiomyocytes Derived from Human Pluripotent Stem Cells.
Ban K; Bae S; Yoon YS
Theranostics; 2017; 7(7):2067-2077. PubMed ID: 28638487
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
